NIKKEI 225
39,676.09 +502.94 (+1.28%) HANG SENG
18,106.20 +33.30 (+0.18%) CRUDE OIL
81.05 +0.22 (+0.27%) GOLD FUTURES
2,326.30 -4.50 (-0.19%) DOW
39,112.16 -299.05 (-0.76%) Bitcoin GBP
49,077.50 +1,449.21 (+3.04%)
TXG Dec 2024 40.000 call
| Previous close | 0.9000 |
| Open | 0.5000 |
| Bid | 0.3500 |
| Ask | 1.3000 |
| Strike | 40.00 |
| Expiry date | 2024-12-20 |
| Day's range | 0.5000 - 0.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 57 |
Insider MonkeyDoes 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Small Company Fund returned 0.48%, significantly underperforming the Russell 2000 Growth index’s 7.58% return. Following the release of the inflation report in February, the […]
PR Newswire10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping its new Xenium Prime 5K Pan-Tissue and Pathways panel. The new panel features an enhanced chemistry to increase plex by an order of magnitude while delivering excellent per-gene sensitivity, improved specificity and spatial fidelity, integrated multimodal cell segmentation and industry-leading speed and throughput.
Simply Wall St.We Think Some Shareholders May Hesitate To Increase 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation
Key Insights 10x Genomics to hold its Annual General Meeting on 11th of June Total pay for CEO Serge Saxonov includes...
